微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 55.11% | 17.96% | 9.71% | 67/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 50.23% | 10.92% | 3.52% | 73/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 48.52% | 9.86% | 1.71% | 77/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 47.71% | 9.55% | 2.12% | 78/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 46.72% | 7.55% | 3.16% | 78/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 45.29% | -9.3% | 2.53% | 84/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 44.17% | -20.38% | 1.42% | 84/139 | 53.23% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 43.55% | -21.68% | 0.26% | 87/139 | 53.35% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 43.44% | -23.58% | -13% | 83/139 | 53.36% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 49.93% | 14.53% | -9.99% | 78/139 | 53.18% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 55.47% | 33.02% | -0.25% | 65/139 | 54.03% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 55.61% | 32.86% | -2.16% | 65/139 | 53.47% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 56.84% | 2% | 30.38% | 60/139 | 53.71% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 43.6% | 7.65% | 4.55% | 89/139 | 53.71% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 41.7% | 2% | -0.38% | 88/139 | 55.18% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 41.86% | 6.74% | 3.36% | 91/139 | 54.84% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 40.5% | -3.28% | 3.27% | 103/139 | 57.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-06-30 | 39.22% | 12.59% | -6.34% | 96/139 | 58.4% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 41.87% | 44.62% | 44.62% | 105/139 | 59.49% | 三友医疗 | 90.29% | 行业排名> |
| 2019-12-31 | 28.95% | -13.03% | -13.03% | 104/139 | 56.29% | 正海生物 | 90.78% | 行业排名> |
| 2018-12-31 | 33.29% | 2% | -4.42% | 93/139 | 55.53% | 正海生物 | 91.59% | 行业排名> |
| 2018-06-30 | 34.83% | 2% | 2% | 44/139 | 51.82% | 正海生物 | 92.23% | 行业排名> |